Variable | Taurine group (n = 60) | Placebo group (n = 60) | MD (95% CI), P-value |
---|---|---|---|
VCAM (µg.ml) | |||
 Before | 3.14 ± 0.94 | 3.82 ± 1.25 | 0.68 (−1.86 to 0.45), 0.230a |
 After | 2.10 ± 0.08 | 3.68 ± 1.15 | −1.67 (−2. 7 to −0.7), 0.001b |
 MD (95% CI), P-valuec | −1.12 (−1.81 to −0.43), 0.002 | −0.14 (−0.4 to 0.13), 0.321 |  |
ICAM (ng/mL) | |||
 Before | 81.22 ± 11.64 | 79.15 ± 9.84 | 2.2 (–1.7 to 5.33), 0.294a |
 After | 68.5 ± 12.25 | 76.2 ± 14.62 | −7.6 (−14.7 to −0.88), 0.029b |
 MD (95% CI), P-valuec | −12.1 (−18.6 to −6.74), 0.001 | −2.49 (−5.9 to 0.1), 0.054 |  |
E Selectin (mg/L) | |||
 Before | 82.42 ± 18.27 | 79.2 ± 24.53 | 3.27(−1.66 to 3.77), 0.153a |
 After | 71.57 ± 14.50 | 77.01 ± 26.27 | −6.1 (−11.3 to −0.68), 0.028b |
 MD (95% CI), P-valuec | −10.94 (−17.6 to −2.87), 0.002 | −1.51 (−5.50 to 0.20), 0.081 |  |
MMP-9Â (ng.ml.) | |||
 Before | 193.65 ± 55.99 | 179 ± 495.46 | 14.6(−7.2 to 38.45), 0.193a |
 After | 140.23 ± 49.82 | 160.55 ± 385.85 | −20.1 (−38.3 to −0.98), 0.049 |
 MD (95% CI), P-valuec | −53.18 (−0.8 to −28.17), 0.001 | −19.1 (−1.50 to 0.20), 0.053 |  |